Harvard Bioscience (HBIO) Deferred Taxes (2010 - 2019)
Harvard Bioscience (HBIO) posted quarterly Deferred Taxes of $42000.0 for Q3 2019, down 74.07% year-over-year from $162000.0 in Q3 2018, and up 4300.0% quarter-over-quarter from -$1000.0 in Q1 2019.
Harvard Bioscience (HBIO) Deferred Taxes (2010 - 2019) Analysis & Trends
Harvard Bioscience (HBIO) has reported Deferred Taxes for 10 consecutive years, with $42000.0 the latest figure, recorded in Q3 2019.
- In Q3 2019, Deferred Taxes fell 74.07% year-over-year to $42000.0; the TTM figure through Sep 2019 stood at -$2.9 million (down 90.12% YoY), while the FY2018 annual figure was -$2.9 million, down 80.62% from the prior year.
- Deferred Taxes advanced to $42000.0 in Q3 2019 per HBIO's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $16.1 million in Q4 2015 and bottomed at -$2.9 million in Q4 2018.
- Historically, Deferred Taxes has averaged $745214.3 across 5 years, with a median of $1000.0 in 2015.
- Annual changes were most pronounced in 2015 — Deferred Taxes slumped 1019.05% — and 2016, when it jumped 14933.33%.
- Harvard Bioscience's Deferred Taxes stood at $16.1 million in 2015, then tumbled by 104.55% to -$734000.0 in 2016, then sank by 115.8% to -$1.6 million in 2017, then sank by 84.79% to -$2.9 million in 2018, then soared by 101.43% to $42000.0 in 2019.
- Business Quant data shows HBIO's Deferred Taxes at $42000.0 in Q3 2019, -$1000.0 in Q1 2019, and -$2.9 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -31.00 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -74.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 64.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -47.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 43.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -34.00 Mn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 42,000.00 |
| Mar 31, 2019 | -1,000.00 |
| Dec 31, 2018 | -2.93 Mn |
| Sep 30, 2018 | 162,000.00 |
| Jun 30, 2018 | 1.26 Mn |
| Mar 31, 2018 | -1.35 Mn |
| Dec 31, 2017 | -1.58 Mn |
| Dec 31, 2016 | -734,000.00 |
| Sep 30, 2016 | 451,000.00 |
| Mar 31, 2016 | 4,000.00 |
| Dec 31, 2015 | 16.14 Mn |
| Sep 30, 2015 | 3,000.00 |
| Jun 30, 2015 | -772,000.00 |
| Mar 31, 2015 | -255,000.00 |
| Dec 31, 2014 | 1.15 Mn |
| Sep 30, 2014 | 140,000.00 |
| Jun 30, 2014 | 84,000.00 |
| Mar 31, 2014 | 35,000.00 |
| Dec 31, 2013 | -729,000.00 |
| Sep 30, 2013 | -411,000.00 |